• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮性卵巢肿瘤中CA125血清水平与二次剖腹手术

CA125 serum levels and secondary laparotomy in epithelial ovarian tumours.

作者信息

Rome R M, Koh H, Fortune D, Cauchi M

机构信息

Oncology Unit, Royal Women's Hospital, Melbourne.

出版信息

Aust N Z J Obstet Gynaecol. 1987 May;27(2):142-5. doi: 10.1111/j.1479-828x.1987.tb00966.x.

DOI:10.1111/j.1479-828x.1987.tb00966.x
PMID:3479113
Abstract

CA125 serum levels were assayed prior to 57 secondary laparotomies for ovarian epithelial tumours. Tumour was present in all 16 patients with an elevated level greater than 35 U/ml but the absence of tumour was incorrectly predicted in 15 of the 33 (45.5%) patients with CA125 levels less than 35 U/ml. For these patients the CA125 level was elevated in 14 of 20 (70%) with tumour greater than 1.5 cm, 1 of 7 (14.3%) with macroscopic tumour less than or equal to 1.5 cm and 1 of 4 (25%) with microscopic tumour. Tumour was resectable to less than or equal to 0.5 cm in 7 of 12 (58.3%) patients with CA125 less than 35 U/ml, 2 of 4 (50%) with CA125 in the range 35-100 U/ml and only 1 of 11 (9.1%) with CA125 greater than 100 U/ml (p less than .05). The CA125 level was elevated in 1 of 13 (7.7%) patients with less than 15 cm3 of tumour compared with 16 of 18 (88.9%) patients with 15 cm3 of tumour or more (p less than .0001). The correlation between the CA125 serum level and the tumour volume was almost statistically significant (r = +0.31, p = .053). The level of CA125 was normal in all 8 patients with mucinous tumours--4 of whom were found to have tumour at secondary surgery.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

对57例卵巢上皮性肿瘤患者进行二次剖腹手术前检测了CA125血清水平。16例CA125水平高于35 U/ml的患者均存在肿瘤,但在33例(45.5%)CA125水平低于35 U/ml的患者中,有15例被错误预测为无肿瘤。对于这些患者,CA125水平在肿瘤大于1.5 cm的20例患者中有14例(70%)升高,在宏观肿瘤小于或等于1.5 cm的7例患者中有1例(14.3%)升高,在微小肿瘤的4例患者中有1例(25%)升高。在CA125低于35 U/ml的12例患者中有7例(58.3%)肿瘤可切除至小于或等于0.5 cm,在CA125在35 - 100 U/ml范围内的4例患者中有2例(50%)可切除至该范围,而在CA125高于100 U/ml的11例患者中只有1例(9.1%)可切除至该范围(p < 0.05)。肿瘤体积小于15 cm³的13例患者中有1例(7.7%)CA125水平升高,而肿瘤体积为15 cm³或更大的18例患者中有16例(88.9%)CA125水平升高(p < 0.0001)。CA125血清水平与肿瘤体积之间的相关性几乎具有统计学意义(r = +0.31,p = 0.053)。8例黏液性肿瘤患者的CA125水平均正常,其中4例在二次手术时发现有肿瘤。(摘要截短于250字)

相似文献

1
CA125 serum levels and secondary laparotomy in epithelial ovarian tumours.上皮性卵巢肿瘤中CA125血清水平与二次剖腹手术
Aust N Z J Obstet Gynaecol. 1987 May;27(2):142-5. doi: 10.1111/j.1479-828x.1987.tb00966.x.
2
[Relationship between serum CA125 level and second-look findings in ovarian cancers].
Zhonghua Zhong Liu Za Zhi. 1992 Jul;14(4):287-9.
3
Evaluation of two new assays for tumor-associated antigens, CASA and OSA, found in the serum of patients with epithelial ovarian carcinoma--comparison with CA125.评估上皮性卵巢癌患者血清中发现的两种肿瘤相关抗原新检测方法CASA和OSA,并与CA125进行比较。
Gynecol Oncol. 1990 May;37(2):165-71. doi: 10.1016/0090-8258(90)90328-i.
4
Evaluation of second-look laparotomy for ovarian cancer: second-look vs. serum CA125.卵巢癌二次剖腹探查术的评估:二次剖腹探查术与血清CA125对比
Chin Med Sci J. 1991 Jun;6(2):96-9.
5
Predictive values of serum tumour markers tetranectin, OVX1, CASA and CA125 in patients with a pelvic mass.
Int J Cancer. 2000 Nov 20;89(6):519-23.
6
CAM26, CAM29 and mucin-like carcinoma associated antigen in epithelial ovarian cancer.上皮性卵巢癌中的CAM26、CAM29及黏蛋白样癌相关抗原
Eur J Gynaecol Oncol. 1990;11(5):395-401.
7
CA125 and placental alkaline phosphatase as serum tumor markers in epithelial ovarian carcinoma.CA125和胎盘碱性磷酸酶作为上皮性卵巢癌的血清肿瘤标志物
Tumour Biol. 1992;13(3):168-74. doi: 10.1159/000217761.
8
OVX1 radioimmunoassay complements CA-125 for predicting the presence of residual ovarian carcinoma at second-look surgical surveillance procedures.OVX1放射免疫测定法可辅助CA-125,用于预测二次探查手术监测程序中残留卵巢癌的存在情况。
J Clin Oncol. 1993 Aug;11(8):1506-10. doi: 10.1200/JCO.1993.11.8.1506.
9
Estradiol, progesterone, 17-hydroxyprogesterone, androstenedione and CA125 in patients with ovarian carcinoma.卵巢癌患者体内的雌二醇、孕酮、17-羟孕酮、雄烯二酮和CA125
Gynecol Endocrinol. 1992 Mar;6(1):25-30. doi: 10.3109/09513599209081003.
10
Prechemotherapy serum CA125 level as a predictor of survival outcome in epithelial carcinoma of the ovary.
Clin Oncol (R Coll Radiol). 1991 Jan;3(1):32-6. doi: 10.1016/s0936-6555(05)81038-6.